Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, January 26, 2022

Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity

This should be old news to your doctor. 

Well your doctor should already have been looking into this from earlier research. 8 years and I bet your stroke hospital has no fucking clue this research even exists.

Psilocybin Magic mushrooms have been found to boost neurogenesis.(Aug. 2013) Science isn’t really sure why. The effect may be because they reduce fear and stress. Psilocybin use has been shown to be effective in treating depression (Mar. 2013) too.

First ever trials on the effects of microdosing LSD set to begin  September 2018

The latest here:

Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity

  • David E. Olson*
Cite this: Biochemistry 2022, XXXX, XXX, XXX-XXX
Publication Date:January 21, 2022
https://doi.org/10.1021/acs.biochem.1c00812
© 2022 American Chemical Society

Read OnlinePDF (1 MB)

Abstract

Abstract Image

In addition to producing profound subjective effects following acute administration, psychedelic compounds can induce beneficial behavioral changes relevant to the treatment of neuropsychiatric disorders that last long after the compounds have been cleared from the body. One hypothesis with the potential to explain the remarkable enduring effects of psychedelics is related to their abilities to promote structural and functional neuroplasticity in the prefrontal cortex (PFC). A hallmark of many stress-related neuropsychiatric diseases, including depression, post-traumatic stress disorder (PTSD), and addiction, is the atrophy of neurons in the PFC. Psychedelics appear to be particularly effective catalysts for the growth of these key neurons, ultimately leading to restoration of synaptic connectivity in this critical brain region. Furthermore, evidence suggests that the hallucinogenic effects of psychedelics are not directly linked to their ability to promote structural and functional neuroplasticity. If we are to develop improved alternatives to psychedelics for treating neuropsychiatric diseases, we must fully characterize the molecular mechanisms that give rise to psychedelic-induced neuroplasticity. Here, I review our current understanding of the biochemical signaling pathways activated by psychedelics and related neuroplasticity-promoting molecules, with an emphasis on key unanswered questions.

 

No comments:

Post a Comment